A Randomized, Double-Blind, Double-Dummy, Safety Crossover Trial Comparing Cumulative Doses up to 96 μg of Formoterol Delivered via an HFA-134a-Propelled pMDI vs. Same Cumulative Doses of Formoterol DPI and Placebo in Asthmatic Patients

Respiration ◽  
2005 ◽  
Vol 72 (1) ◽  
pp. 28-34 ◽  
Author(s):  
M. Molimard ◽  
E. Guenolé ◽  
T. Duvauchelle ◽  
E. Vicaut ◽  
G. Lefrançois
Sign in / Sign up

Export Citation Format

Share Document